IBOV 186,340.46 ▲ 1.37% IPSA 10,969.49 ▼ 0.78% IPC MEX 64,951.10 ▼ 0.24% MERVAL 2,819,323 ▲ 1.32% COLCAP 2,549.16 ▼ 0.38% BVL PERÚ 60,410.88 ▼ 0.96% USD/BRL5.18▼ 0.34% USD/MXN18.10▲ 0.31% USD/CLP972.03▼ 0.10% USD/COP3,292▼ 2.26% USD/PEN3.45▲ 0.23% USD/ARS1,525▼ 0.03% USD/UYU40.24▲ 3.55% USD/PYG5,817▲ 2.25% USD/BOB11.97▲ 0.66% USD/DOP59.27▲ 0.12% USD/CRC454.26▲ 3.19% USD/GTQ7.64▲ 3.18% USD/HNL26.86▲ 0.43% USD/NIO36.62▲ 0.34% USD/VES856.92▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.72▲ 2.14% EUR/BRL5.87▼ 1.12% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 186,340.46 ▲ 1.37% IPSA 10,969.49 ▼ 0.78% IPC MEX 64,951.10 ▼ 0.24% MERVAL 2,819,323 ▲ 1.32% COLCAP 2,549.16 ▼ 0.38% BVL PERÚ 60,410.88 ▼ 0.96% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Thursday, October 1, 2026

Argentina Egypt

New dengue and chikungunya genotypes detected in Argentina: what is the risk?

By · April 20, 2023 · 2 min read

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Colombia decides rates today, near its own debt ceiling”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

With more than 30 deaths due to diseases transmitted by the Aedes aegypti mosquito, Argentine health authorities identified at least two new genotypes of dengue and chikungunya circulating in the country.

This strain could increase the risk of serious infections.

Amid an exponential increase in registered cases of dengue fever in Argentina, the Ministry of Health warned of new genotypes circulating in the country.

Free daily brief — no card needed
Get every Argentina story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.
Aedes aegypti mosquito
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

Genotypes are genetic information grouped into serotypes, a form of classification of infectious microorganisms that allows them to be differentiated.

Health authorities reported the detection of Genotype II-Cosmopolitan (serotype 2) in samples studied, demonstrating the introduction of a new subvariant to the country.

Although detected for the first time in Argentina, it is not new in the region, having been reported in Peru in 2019 and Brazil in 2021.

Historically, the DENV-1 genotype (serotype 1) has circulated in Argentina.

In addition, a genotype within serotype 2 (DENV-2) from Southeast Asia had already been detected until 2022.

The finding poses a greater health risk since if a person is infected by one serotype and bitten by a different one, the probability of suffering from severe dengue fever is greater.

The risk even increases if the second infection is caused by serotype 2, according to the Argentine Ministry of Health.

Unlike previous epidemics such as those of 2009, 2016, and 2020, serotype 2 is the one that predominates in the Argentine territory at present, detected in 10 of the 15 jurisdictions affected by this disease.

As for chikungunya, authorities identified for the first time the presence of the ECSA genotype, which refers to Eastern, Central, and Southern Africa, currently predominant in Brazil and Paraguay.

According to the latest epidemiological bulletin, dated April 8, Argentina registered 41,257 cases of dengue and 1,092 of chikungunya, most of which were contracted in the country.

So far, the dengue virus has been identified in 15 jurisdictions and chikungunya in eight.

With information from Sputnik

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.